The generic forms: Similarities, bioequivalence but no conformity;Les génériques: Essentiellement similaires, bioéquivalents mais non identiques

Journal de Pharmacie de Belgique

Volumn 57, Issue 1, 2002, Pages 14-20

  Even Adin, D ^a   De Muylder, J A ^a   Sternon, J ^a  

^a NONE   (Belgium)

Author keywords

Biodisponibility; Generic forms; Repayment; Sale's authorization; Similarity

Indexed keywords

AMIKACIN; AMIODARONE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMOXIPHAR; ANTIVITAMIN K; BLEOMYCIN; CARBAMAZEPINE; CIPROFLOXACIN; CYCLOSPORIN; CYTARABINE; DIGOXIN; DOCAMOXI; DONEPEZIL; ELVORINE; GALANTAMINE; GENERIC DRUG; INSULIN; LEVOFLOXACIN; LEVOTHYROXINE; NEXIAM; PHENYTOIN; PROTON PUMP INHIBITOR; RANITIDINE; RIVASTIGMINE; VERAPAMIL;

BELGIUM; BIOEQUIVALENCE; BUDGET; DRUG MARKETING; DRUG QUALITY; DRUG UTILIZATION; REVIEW;

BELGIUM; DRUG INDUSTRY; DRUGS, GENERIC; HUMANS; THERAPEUTIC EQUIVALENCY;

EID: 18244420816     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Les génériques autorisation de mise sur le marché et garanties de qualité
2. Biodisponibilité et bioéquivalence
3. Les médicaments génériques
4. Les soins pharmaceutiques, interview de A. Peeters, conseillère
5. Generic substitution and optimal patient care
6. Responsabilité et médicaments génériques
7. Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias
8. A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: A case for carbamazepine
9. Bioequivalency revisited: Epitol versus tegretol
10. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism
11. Generic warfarin: Implications for patient care
12. Development of Sang-35: A cyclosporine formulation bioequivalent to Neoral